Guzip Biomarkers Corporation
PrivateLast Round
Seed
Mar 1, 2019
Company Overview
Guzip Biomarkers Corporation is a biotechnology company that develops DNA methylation-based diagnostic tools for the detection of endometrial cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guzip Biomarkers Corporation Comparables
Compare Guzip Biomarkers Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iStat Biomedical Co., Ltd. | 89% | |
| Epitype GmbH | 89% | |
| Self-screen B.V. | 86% |
Guzip Biomarkers Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 1, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2025
Monthly visitors increased 53% MoM, reaching 1.4K.
- Apr 18, 2025
Monthly visitors increased 153% MoM.
Guzip Biomarkers Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Guzip Biomarkers Corporation's valuation, stock price, and market status.
Is Guzip Biomarkers Corporation a public or private company?
Guzip Biomarkers Corporation is a private company.
What is the current stock price of Guzip Biomarkers Corporation?
Guzip Biomarkers Corporation is a private company, so its shares have no public market price. Caplight tracks Guzip Biomarkers Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Guzip Biomarkers Corporation worth (valuation)?
Valuation information for Guzip Biomarkers Corporation is not publicly available.
Can I buy Guzip Biomarkers Corporation stock?
Guzip Biomarkers Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Guzip Biomarkers Corporation's last funding round?
Guzip Biomarkers Corporation's most recent funding round was Seed on March 1, 2019.
Who are the main investors in Guzip Biomarkers Corporation?
Investor information for Guzip Biomarkers Corporation is not publicly disclosed.
Will Guzip Biomarkers Corporation IPO soon?
No public IPO plans have been announced for Guzip Biomarkers Corporation.
How can I track Guzip Biomarkers Corporation secondary market activity?
Caplight tracks bids, offers, and trades in Guzip Biomarkers Corporation's shares on secondary markets.